Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Kelt's Profile
Displaying 1051-1100 of 2957 result(s).
IPIX Innovation Pharmaceuticals Inc
10/18/2018 12:19:07 PM
I see three options. 1) Buy shares (5)
IPIX Innovation Pharmaceuticals Inc
10/16/2018 10:02:48 PM
We all know what the "agenda" is.Th (9)
IPIX Innovation Pharmaceuticals Inc
10/15/2018 8:19:11 PM
Scotty referring to Leo as a bottom (5)
IPIX Innovation Pharmaceuticals Inc
10/15/2018 12:13:52 PM
How about deleting worthless posts (2)
IPIX Innovation Pharmaceuticals Inc
10/13/2018 9:01:08 PM
Funny thing,those selective memorie (2)
IPIX Innovation Pharmaceuticals Inc
10/13/2018 4:27:28 PM
I think both of you may be right as (2)
IPIX Innovation Pharmaceuticals Inc
10/13/2018 9:21:11 AM
Call the "POOP PATROL" I think you
IPIX Innovation Pharmaceuticals Inc
10/12/2018 8:51:27 PM
They are "soft" and sometimes "medi (2)
IPIX Innovation Pharmaceuticals Inc
10/12/2018 8:46:37 PM
Funny how the "minions" try to turn (4)
IPIX Innovation Pharmaceuticals Inc
10/12/2018 9:56:49 AM
"It's called distort and it has wo (4)
IPIX Innovation Pharmaceuticals Inc
10/12/2018 9:49:50 AM
" All the recent volume is selling (5)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 10:19:45 PM
Oh!! There's one now Double J !! Ke
IPIX Innovation Pharmaceuticals Inc
10/11/2018 10:17:43 PM
Maybe you can get the negative yo-y (2)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 10:06:08 PM
Boy you got that one right!!! Kelt
IPIX Innovation Pharmaceuticals Inc
10/11/2018 5:29:31 PM
Re-read my post as to why. If they (1)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 5:23:24 PM
NO,it is YOU who don't understand t (1)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 4:48:04 PM
Back when he dealt with Aspire in J (2)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 4:34:15 PM
Couldn't have said it better myself (1)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 4:30:51 PM
Shame that some people don't unders
IPIX Innovation Pharmaceuticals Inc
10/11/2018 4:26:06 PM
He didn't need to have the deal wit
IPIX Innovation Pharmaceuticals Inc
10/11/2018 3:52:19 PM
I may be wrong but Leo could have j (6)
IPIX Innovation Pharmaceuticals Inc
10/11/2018 9:16:58 AM
It is what it is.
IPIX Innovation Pharmaceuticals Inc
10/10/2018 8:49:09 PM
Priority Review could/would be used
IPIX Innovation Pharmaceuticals Inc
10/10/2018 8:43:51 PM
This is the list of criteria for a (2)
IPIX Innovation Pharmaceuticals Inc
10/10/2018 4:10:09 PM
Another thought is that in order t (4)
IPIX Innovation Pharmaceuticals Inc
10/10/2018 1:58:10 PM
Drano,DoubleJ123 or any long term (3)
IPIX Innovation Pharmaceuticals Inc
10/09/2018 4:15:02 PM
So many "negative numbskulls" runni (8)
IPIX Innovation Pharmaceuticals Inc
10/06/2018 10:11:12 PM
I am so sick and tired of those who (5)
IPIX Innovation Pharmaceuticals Inc
10/06/2018 3:40:55 PM
Bashing.The word actualy defines it (4)
IPIX Innovation Pharmaceuticals Inc
10/06/2018 11:20:28 AM
Different points of view are not th (5)
IPIX Innovation Pharmaceuticals Inc
10/05/2018 2:16:57 PM
I agree because they obviously don'
IPIX Innovation Pharmaceuticals Inc
10/03/2018 8:16:44 PM
The negative ID is to scare and the (1)
IPIX Innovation Pharmaceuticals Inc
09/29/2018 8:36:48 PM
Great posts Mo but your #'s are qui (4)
IPIX Innovation Pharmaceuticals Inc
09/29/2018 8:23:37 PM
NOT GOING TO HAPPEN!!! Kelt (2)
IPIX Innovation Pharmaceuticals Inc
09/29/2018 4:33:10 PM
A:Celgene is not a good example and
IPIX Innovation Pharmaceuticals Inc
09/29/2018 3:42:58 PM
I will not agree or disagree with y (5)
IPIX Innovation Pharmaceuticals Inc
09/28/2018 5:26:31 PM
I also don't think Leo plans on loo (4)
IPIX Innovation Pharmaceuticals Inc
09/28/2018 4:41:46 PM
You're not anywhere near being in m (9)
IPIX Innovation Pharmaceuticals Inc
09/28/2018 11:04:15 AM
In spite of all the successes and p (3)
IPIX Innovation Pharmaceuticals Inc
09/28/2018 10:28:55 AM
Nothing has changed. Successful tr (2)
IPIX Innovation Pharmaceuticals Inc
09/26/2018 7:47:19 PM
Think of final DD like buying real (5)
IPIX Innovation Pharmaceuticals Inc
09/26/2018 2:24:06 PM
BINGO!!! Some of us have been sayin (3)
IPIX Innovation Pharmaceuticals Inc
09/24/2018 2:31:04 PM
Squirrels on the board are luckier (5)
IPIX Innovation Pharmaceuticals Inc
09/24/2018 2:09:23 PM
I know .That's why I don't use it e
IPIX Innovation Pharmaceuticals Inc
09/24/2018 10:58:40 AM
The only shortfall with the ignore (1)
IPIX Innovation Pharmaceuticals Inc
09/24/2018 9:14:20 AM
Funny that the multi ID's talk abou (3)
IPIX Innovation Pharmaceuticals Inc
09/23/2018 8:33:16 PM
I think I love you!!! Kelt
IPIX Innovation Pharmaceuticals Inc
09/23/2018 1:42:25 PM
Well here we are folks at the last (12)
IPIX Innovation Pharmaceuticals Inc
09/23/2018 1:40:12 PM
Ahhh Yes. A little word twisting he (2)
IPIX Innovation Pharmaceuticals Inc
09/20/2018 8:52:39 PM
I'm not really sure to be honest.I
Go to page:
  • << First
  • < Previous
  • 21
  • 22
  • Next >

Recent Articles

  • DAESHIN MC Introduces Innovative Solutions at BEX ASIA 2025
  • Mighty Bolton's Art of Dialogue: Journey to Global Fame
  • Celebrating 13 Years of Groundbreaking Laser Hair Removal
  • Cathie Wood’s Strategic Moves: Airbnb Gains and Selling Trends
  • DermRays Marks 13 Years of Leading Innovation in Beauty Tech
  • Driving the Future: The Expanding Automotive Smart Antenna Sector
  • O2Gold Increases Financing While Finalizing Quebec Acquisition
  • American Bitcoin's Future at NASDAQ: A Transformative Journey
  • O2Gold Progresses on Quebec Acquisition and Offers Financing Plans
  • Southwest Gas Holdings Reveals Key Pricing Details for Centuri Offering
  • Exploring the Growth of the Pressure Monitoring Market
  • FLINT Corp's Bold Move to Reshape Its Financial Future
  • Investigation into Mr. Cooper Group and Other Companies
  • BioVie Inc. Launches $12 Million Fundraising Initiative
  • FLINT Corp. Unveils Strategic Recapitalization Plan for Growth
  • Growth Forecast for Anhydrous Hydrofluoric Acid Market
  • BioVie Inc. Secures $12 Million in Innovative Offering
  • Key Insights on Potential Shareholder Benefits for AMWD, PHLT, STAA
  • Celebrating Indigenous Art: The Virtual Evolution of DAAF
  • Innovative Warehouse Solutions & Passport Partnership Fuels E-Commerce Growth
  • Critical Information for Alto Neuroscience Investors Ahead of Deadline
  • California Hotel Association Celebrates Crime Prevention Progress
  • Growth of Performance Food Group: A 5-Year Investment Story
  • Rocket Pharmaceuticals Faces Class Action for Investor Losses
  • Manulife Expands Asian Equities Team with Key Leadership Roles
  • Wi-Fi 7 Growth Opportunities and Market Insights for 2025
  • Expanding Horizons: Specialty Enzymes Market Trends 2029
  • Etoiles Capital Group Successfully Prices IPO for Growth
  • Verisk Analytics Unveils $1.5 Billion Senior Notes Offering
  • Hagerty's Class A Common Stock Offering: Details and Insights
  • A Closer Look at Rocket Lab USA's Stellar Q2 Performance
  • Maximizing Investment Returns: The Success of Cameco Corp
  • Lundin Gold Achieves Record Revenue and Strong Future Outlook
  • Join Global Investors at Costa Rica's Premier Business Summit
  • Revamping Rail Travel: Amtrak's NextGen Acela Launch Highlights
  • Engaging Global Investors: A Business Summit in Costa Rica
  • Vera Bradley, Inc. Investigates Shareholder Rights and Claims
  • Sarepta Therapeutics Investors Encouraged to Join Class Action
  • GeneDx Holdings Corp Faces Investor Claims Amid Fraud Allegations
  • Inspire Medical Systems Faces Legal Scrutiny: Investor Alert
  • Important Legal Details for Western Asset Fund Investors
  • Massive Lawsuit Filed Against Novo Nordisk: Investors Alert
  • The Keg Royalties Income Fund's Strategic Move with Fairfax
  • Keg Royalties Fund Gains Approval for Acquisition by Fairfax
  • Investors Urged to Act Before Lead Plaintiff Deadline in DDD Case
  • Transforming $100 into $528.77: A Teledyne Investment Journey
  • Exploring Walmart's Stock Growth Over the Past Decade
  • Mount Logan Capital Reports Strong Q2 2025 Financial Performance
  • The Trade Desk Q2 Performance Insights and Future Strategy
  • PayPal's New Leadership Fuels Growth Amid Market Challenges
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site